We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$75.5B
AUM Growth
+$6.03B
Cap. Flow
+$664M
Cap. Flow %
0.88%
Top 10 Hldgs %
13.76%
Holding
1,022
New
110
Increased
407
Reduced
342
Closed
107

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$440M
2
QCOM icon
Qualcomm
QCOM
+$412M
3
BIDU icon
Baidu
BIDU
+$207M
4
UPS icon
United Parcel Service
UPS
+$185M
5
KO icon
Coca-Cola
KO
+$168M

Sector Composition

Rank Sector Weight
1 Energy 16.71%
2 Financials 13.65%
3 Communication Services 11.71%
4 Technology 11.31%
5 Healthcare 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLPH icon
826
Talphera
TLPH
$70.1M
$3.65M ﹤0.01%
+16,929
New +$3.69M
ASCMA
827
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$3.63M ﹤0.01%
45,085
+13,085
+41% +$1.03M
NSU
828
DELISTED
Nevsun Resources Ltd.
NSU
$3.58M ﹤0.01%
+1,130,000
New +$3.67M
NFG icon
829
National Fuel Gas
NFG
$7.84B
$3.54M ﹤0.01%
51,410
+3,260
+7% +$212K
CAM
830
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$3.5M ﹤0.01%
60,000
-767,239
-93% -$45.7M
ANV
831
DELISTED
Allied Nevada Gold Corp
ANV
$3.34M ﹤0.01%
800,000
-2,179,300
-73% -$11.4M
NWSA icon
832
News Corp Class A
NWSA
$14.5B
$3.32M ﹤0.01%
+206,662
New +$3.3M
BKLN icon
833
Invesco Senior Loan ETF
BKLN
$7.1B
$3.14M ﹤0.01%
127,060
INFY icon
834
Infosys
INFY
$45B
$3.08M ﹤0.01%
511,920
-1,351,096
-73% -$8M
WY icon
835
Weyerhaeuser
WY
$17.3B
$3.01M ﹤0.01%
+105,250
New +$2.98M
TTWO icon
836
Take-Two Interactive
TTWO
$43B
$3M ﹤0.01%
+165,000
New +$2.89M
MACK
837
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.83M ﹤0.01%
94,707
-114
-0.1% -$3.99K
GORO icon
838
Goldgroup Mining Inc.
GORO
$151M
$2.65M ﹤0.01%
+400,000
New +$3.17M
NAV
839
DELISTED
Navistar International
NAV
$2.61M ﹤0.01%
71,623
EEM icon
840
iShares MSCI Emerging Markets ETF
EEM
$28B
$2.58M ﹤0.01%
+63,400
New +$2.51M
NDLS icon
841
Noodles & Co
NDLS
$90.5M
$2.56M ﹤0.01%
+7,511
New +$2.61M
DOC
842
DELISTED
PHYSICIANS REALTY TRUST
DOC
$2.54M ﹤0.01%
+209,480
New +$2.45M
BBVA icon
843
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$2.49M ﹤0.01%
233,990
+87,187
+59% +$804K
APL
844
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
$2.49M ﹤0.01%
64,109
+31,623
+97% +$1.2M
QLTI
845
DELISTED
QLT Inc
QLTI
$2.46M ﹤0.01%
530,670
HYG icon
846
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$2.39M ﹤0.01%
80,000
LVLT
847
DELISTED
Level 3 Communications Inc
LVLT
$1.87M ﹤0.01%
70,000
SCG
848
DELISTED
Scana
SCG
$1.84M ﹤0.01%
40,020
-149,310
-79% -$7.36M
WDAY icon
849
Workday
WDAY
$33.4B
$1.84M ﹤0.01%
22,700
-30
-0.1% -$2.19K
SBSW icon
850
Sibanye-Stillwater
SBSW
$5.92B
$1.56M ﹤0.01%
+318,240
New +$1.16M

Similar funds

OppenheimerFunds's Q3 2013 Portfolio in Review

As of Q3 2013, OppenheimerFunds held 1,022 positions worth $75.5B, up 8.7% from $69.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

OppenheimerFunds's Q3 2013 filing shows 110 new, 407 increased, 342 reduced and 107 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M. The largest sale was Allergan plc, an estimated $440M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.

  • OppenheimerFunds's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M.
  • OppenheimerFunds added most to Televisa in Q3 2013, an estimated $308M increase.
  • OppenheimerFunds's biggest Q3 2013 reduction was Allergan plc, cutting an estimated $440M.
  • OppenheimerFunds fully exited BROADCOM CORP CL-A in Q3 2013, selling an estimated $164M.
  • OppenheimerFunds's ten largest holdings make up 14% of its $75.5B portfolio in Q3 2013.
  • OppenheimerFunds opened 110 new positions and closed 107 in Q3 2013.
  • OppenheimerFunds's portfolio value rose 8.7% quarter-over-quarter to $75.5B.

Based on OppenheimerFunds's 13F filing for Q3 2013, filed 14 Nov 2013.